← Open Payments lookup

H MOHANKUMAR: Open Payments

NPI 1114080314 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,639 in 19 payments from 7 companies in 2025. Trend: 2023 $2,482 · 2024 $1,692 · 2025 $1,639

Food & beverage: $1,639
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc4$396
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$297
Alkermes, Inc.3$279
Otsuka America Pharmaceutical, Inc.2$235
E.R. Squibb & Sons, L.L.C.3$182
Teva Pharmaceuticals USA, Inc.2$125
Vanda Pharmaceuticals Inc.1$125

Products named: CAPLYTA, INVEGA SUSTENNA, LYBALVI, COBENFY, UZEDY, REXULTI, SPRAVATO, FANAPT.

Industry payments across CA — which companies pay providers there.